P u m : Recent revision of the lissencephaly critical region on chromosome 17p13.3 and confirmation of LlSl as the causative gene for classical lissencephaly has allowed the development and application of fluorescence in situ hybridization (FISH) probes corresponding directly to this gene. Method: We have analyzed patients with isolated lissencephaly sequence (ILS) by FlSH with probes at D17S379, an anonymous locus distal to LIS1, and with LlS1 specific probes. Results: In 110 patients with ILS, a deletion at D17S379 was detected in 23.6%. Of those patients without a deletion, 32 were available for further study with LlSl probes. Deletions were found in eight additional individuals. Conclusion: The overall deletion mutation rate detectable by FlSH with LlSl probes is ~4 0 % . This rate is significantly higher than the deletion rate observed at D17S379. This indicates that FlSH studies using probes specific to LISl should be undertaken as the initial diagnostic assay for the evaluation of patients with ILS, and the high frequency of deletions raises the possibility of "hotspots" for chromosome breakage in this region.
MROWC'llON
more telomeric gene on 17p." The correct 5'-end Classical lissencephaly is a disorder of neuronal of LISl has now been identified and the critical migration characterized by agyria or pachygyria with region for lissencephaly revised. 12 Mutations within an abnormally thick cerebral cortex It merges with this gene were identified in several nondeletion subcortical band heterotopia (SBH), also known as patients with ILS, thus providing the final confir-"double cortex", to form the agyria-pachygyria band mation that LISl is the 17p lissencephaly gene.I3 spectnun of cortical malformations. Three major synLISl is known to encode a subunit of the brain &ma have been identified with classical hse&phaly or SBH: Wer-Dieker syndrome localized to duomosome 17~13.3; isolated lissencephaly sequence (ILS17). associated with abnormalities of 17~13.3; and X-linked lissencephaly (ILSX), in which affected males have the agyriclpachygyric form of classical lissencephaly and carrier females show SBH.'s2
Patients with ILS have classical lissencephaly of variable severity with few dysmorphic features. These include a square forehead, short nose, thin upper lip, and small jaw. They are profoundly retarded, and the vast majority have seizures." Visible deletions of 17~13.3, seen in more than 50% of patients with Miller-Dieker syndrome, have never been reported in patients with ILSS and were not seen in our present series; however, since submicroscopic deletions of this region were first reported in 1991,"' they have been identified in an increasing number of patients.
-
Two series using cosmid probes corresponding to D17S379 for fluorescence in situ hvbridization (FISH) studies showed a detection rate of 13%8 and'18%) respectively, for ILS.
In 1993 a gene, LISl, was mapped to 17~13.3 and proposed as a candidate gene for lis~encephaly.'~ Subsequently, it was found that one of the cDNA clones used in the determination of the 5'-end of LISl was chimeric and, in fact, was derived from a platelet-activating factor acetylhydrolase (PAFAH),14 although its precise role in neuronal migration has yet to be determined.
In view of the revised map of the lissencephaly region,I2 we have developed further genomic probes partially or completely spanning the LISl gene for deletion assessment by FISH. We present our FISH data on 110 patients with ILS and demonstrate that the LISl probes significantly increase the deletion detection rate in these patients to -40%.
MATERIALS AND METHODS

Subjects
All 110 patients, 60 males and 50 females, were evaluated by one of the authors (D.T.P. or W.B.D.) to confirm the diagnosis of ILS. This included a review of the clinical data and the cranial CT or MRI scan in all cases. If the patient could not be examined in person, photographs were used to document the facial phenotype. Details of the phenotype, including appearance, radiological and pathological abnormalities, and clinical course observed in ILS, have been published el~ewhere.'-~~* Blood samples from the probands, and in some cases their parents, were obtained with informed consent. All protocols were approved by the appropriate Human Subjects Committee Institutional Review Board.
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are s h o k in Figure 1 . Patients initially were screened for deletions at D17S379 with a small cosmid contig (~197-9, ~197-4, and ~197-2) used as a pooled probe of =80 kb as described previouslys Additional genomic clones proximal to LISl included c136FlOI93E5 and c115B3. These were used before the identification of the LISl gene and corresponding genomic clones. Of several LISl -specific clones, c120A7 and PAC-95H6, estimated to be ==35 kb and =I10 kb in size, respectively, were primarily used. The PAC done 95H6 contains both the 5'-and 3'-ends of the LISl gene. Details and availability of the clones have been published elsewhere.I2
Fluorescence In sit^^ h y b r i d i i Chromosome preparations were made from peripheral blood or lymphoblastoid cell lines by standard methods. FISH analysis was carried out as described previously12 with minor modifications.
Cosmid and PAC DNA, labeled with digoxigenin-1 1-deoxyuridine triphosphate (dUTP; Boehringer Mannheim, Indianapolis, IN) were precipitated in ethanol with 30X excess of human Cot-1 DNA and herring testis DNA (Gibco-BRL) and resuspended to a final concentration of 20 ng/p,L in hybri&tion solution (50% formamidel2 X saline sodium citrate (SSC)/lO% dextran sulfate). After addition of chromosome 17 a-satellite robe labeled with biotin-16-dUTP (Boehringer ~annheim), the probes were denatured at 76' C for 7 minutes and preannealed at 37' C for 15 minutes.
The probe mixture (6 pL) was applied under a 22 mm x 11 mm coverslip, and slides were incubated in a moist chamber at 37' C for 16 hours. The probes were detected in 60 @ of rhodamine anti-digoxigenin (Boehringer Mannheim) at 1 pg/pL and fluorescein isothiocyanate (F1TC)-avidin DCS (Vector Laboratories, Burlington, CA) at 5 pg/pL. At least 10 metapham were analpxi for each hybridization using a Zeiss Axiophot microscope with filters to detect $6-diamidino-2-phenyltndole (DAPI), fluorescein isothiocyanate, and rhodarnine separately as well as a triple band pass filter (no. 83000, Chroma Technology Corp., Brattleboro, VT) to detect signals simultaneously. Images were collected and merged using a cooled CCD camera (KAF 1400 Photometrics, Tuscon, AZ) and
RESULTS
Of the 110 patients tested with probes at D17S379 deletions were detected in 26 patients (23.6%). Thid deletion frequency is W e r than in the previous twQ series on smaller numbers of patients8, due use of the more stringent diagnostic criteria o the last few years. Further analysis in 16 o f t deleted patients with probes located centrome the LISI, or more recently with the LZS c120A7, PAC-95H6, and c37E9 ( Fig. 1) dence of a deletion of the entire LISl i uals (Fig. 2, A and B) , whereas one represented a'
uartial deletion of the gene (discussed below). * Of the patients not deleted at D17S379,32 available for study with the US1 probes c120A7, 95H6, and c37E9. Deletions were found in an tional eight of these patients ( Fig. of the children had a deletion of whereas one had a partial LISl dele Overall, deletion status for PAC LISI, was tested directly or could FISH data on flanking probes in a to of whom 16 were deleted and 3 at D17S379.
A complete deletion of U S 1 was identified in 22 of 48 cases. A partial gene deletion was observed in two patients. They had previously shown with probes telomeric or centromeric 3'-end of the gene. The second child w at D17S379 (Fig. 3B) ; however, he wa mosaic for a deletion (80% of cells) gene and the U S 1 probe c120A7. The nal was visible on both 17 homolo on the two 17 homologues assisted in interpretation (more evident in case 2, Fig. 3B ). In each case, the homologue with the smaller a-satellite signal was the deleted chromosome 17 and the one with a weaker signal when analyzed with PAC-95H6. Although we would not base a final diagnosis solely on the data from PAC-95H6, a significantly weaker signal seen on one chromosome 17 should alert an investigator to the possibility of a partial gene deletion and warrant further FISH or molecular testing. Overall, deletions at D17S379 were observed in 26 (23.6%) of 110 patients with ILS. The LIS1 -specific probes detected eight additional deletions in 32 nondeleted patients (25%). We estimate that among the 84 patients not deleted at D17S379, deletions would be detected in approximately 21 if all could be tested with LISl probes. This would correspond to a deletion detection rate of 43%, considerably higher than that for D17S379.
Of the 34 of 110 patients in our study who were found to be deleted, a slightly higher percentage of deletions was detected in females (17 of 50; 34%) compared with males (17 of 60; 28.3%), but was not statistically significant (0.50 < P < 0.75).
DISCUSSION
Final confirmation of LISl as the causative gene in classical lissencephaly and revision of the critical region in 17~13.3 has allowed the development of a series of genomic probes corresponding directly to the gene. Using these clones as FISH probes greatly increased the detection rate of deletions in patients with ILS. PAC-95H6, which completely spans LISl and contains both the 5'-and 3'-ends of the gene (Fig. I) , is the most informative single probe for the identification of deletions in ILS patients. Some partial deletions of the LISl gene may not be detected with a single FISH probe. In our series, two patients showed sigdicantly weaker, rather than absent, hybridization to one 17 homologue with PAC-95H6. An alternative strategy for deletion detection would be to use two separate clones representing the 5'-and 3'-ends of the LISl gene, e.g., c37E9 and c120A7, which would permit detection of some cases of a partial deletion. Since the present data indicate that most patients are deleted for the entire LISl gene, it is probably most cost-effective for the initial clinical laboratory evaluation to be performed by analysis of a single probe.
Among the patients with ILS in whom we did not detect a deletion with FISH, smaller deletions or point mutations of the LISl gene cannot be excluded. Intragenic mutations have so far been reported in eight patients.l3, l5 The majority of these mutations (four frameshift, one nonsense, two splice site, and one missense) result in a truncated protein. This observation, coupled with the comparatively high deletion rate in ILS in our study, indicates that there is likely to be an ascertainment bias toward more severely affected patients. Patients with less severe cerebral malformations, such as generalized or partial pachygyria, may not be commonly recognized as part of the classical lissencephaly spectrum. If so, the diagnosis of ILS may be missed, and the patients may not be referred for evaluation.
Another cause of classical lissencephaly is mutations of XLIS (aka DCX).16. l7 A girl with classical lissencephaly and a de novo X;2 translocation? and several families in which affected males had classical lissencephaly (whereas first-degree female relatives had SBH)l8, l9 suggested an X-linked form of classical lissencephaly (XLISISBH). Mapping of the translocation breakpoint in the above patient to Xq22.3 and linkage of families with XLISISBHDC to an interval on the X chromosome containing the b r e a k p~i n t~~.~' led to the identification of the abovementioned XLIS gene. Mutations were reported in seven familial cases of ILSXJSBH and in five sporadic females with SBH.l6," This implied that some of the males with ILS, in whom no deletion of LISl is detected, may have mutations of the XLIS gene. We recently confirmed this in a study of XLIS in males with sporadic ILS. 22 In terms of counseling, the possibility of X-linked lissencephaly will always have to be considered in a nondeleted male with the diagnosis of ILS, particularly if there is a history of seizures or learning difficulties in his mother or other first degree female relatives, because these are features associated with subcortical bands in carrier females. Our current studies comparing the lissencephaly in boys with ILSX to children with ILS17 and LISl mutations, show consistent differences on neuroimaging, which help suggest which gene is involved." So far all changes involving XLIS have been intragenic m~tations.'~. I' Our observations of several children with complex lissencephaly phenotypes indicate, that other autosomal forms of classical lissencephaly exist, although they appear to be less common than those associated with alterations of LISl. Examples include the children described by Ramer et al.23 with classical lissencephaly and several additional malformations and those with classical lissencephaly and significant congenital microcephaly. ' Deletions in ILS have so far always been de novo; although, when found, parental studies are recommended to exclude the unlikely event of a balanced insertional translocation. Phenotypically, there was no apparent difference between the patients who were also deleted at D17S379 and those deleted only for LISl. The recurrence risk associated with de novo deletions is very low, mainly conferred by the possibity of germline mosaicism which has not yet been reported in association with this condition. Ultrasonography is not a reliable method to detect classical lissencephaly during pregnancy, particularly in the first and second trimesters.24," Therefore, detecting such a deletion in an affected child, not only confirms the diagnosis but the very low recurrence risk is reassuring to a couple wishing to extend their family. If requested, accurate prenatal diagnosis by FISH analysis can be offered.
The recurrence risk for parents of children with ILS and no known deletion or mutation of LISl appears to be low. Our previous study of 60 patients with 41 siblings cited a recurrence risk of 7%.3 This figure was based on the observation of three affected siblings from two families out of the total of 41 siblings. Reviewing the data from that paper we determined that the proband and the affected sibling from one of the families was classified incorrectly as having ILS. The other family consisted of three affected brothers. We now suspect that these three boys had X-linked lissencephaly, but have not yet been able to confirm this. No affected siblings (exact number not determined) were identified in any of the families of the 110 patients reported here. Therefore, we estimate that the recurrence risk for ILS, based on this series and our experience, should be significantly less than 5%, especially for families with an affected daughter. The risk for families with affected boys is likely to be slightly higher, because X-linked lissencephaly is a possibility.
The development of LISl gene-specific probes for FISH deletion studies in patients with ILS has increased the detection rate allowing accurate counseling in a greater number of patients. The single clone PAC-95H6 contains the entire LISl gene and will detect all cases of complete gene deletion, making it the most efficient single probe for , & i d inwtigation of classical lissencephaly patients.
